Page last updated: 2024-11-05

hydroxyhydroquinone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Hydroxyhydroquinone, also known as 1,2,4-trihydroxybenzene, is a trihydroxybenzene derivative that has been studied for its potential applications in various fields. It exhibits antioxidant properties, which have led to investigations into its potential use in treating oxidative stress-related conditions. It is also being explored for its potential as a building block in the synthesis of complex organic molecules, including natural products and pharmaceuticals. Hydroxyhydroquinone can be synthesized through various chemical reactions, including the reduction of 1,2,4-trihydroxybenzene or the oxidation of hydroquinone. Research is ongoing to explore its full potential in various applications.'

benzene-1,2,4-triol : A benzenetriol carrying hydroxy groups at positions 1, 2 and 4. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID10787
CHEMBL ID3092389
CHEBI ID16971
SCHEMBL ID33527
MeSH IDM0060473

Synonyms (61)

Synonym
AC-12373
173o8b04rd ,
4-06-00-07338 (beilstein handbook reference)
unii-173o8b04rd
oxyhydrochinon
wln: qr bq dq
2,5-dihydroxyphenol
hydroquinone, hydroxy-
1,4-trihydroxybenzene
nsc-2818
1,4-benzenetriol
nsc2818
benzene-1,4-triol
CHEBI:16971 ,
1,3,4-benzenetriol
4-hydroxycatechol
C0264
ai3-19361
oxyhydrochinon [german]
einecs 208-575-1
brn 2042863
1,3,4-trihydroxybenzene
oxyhydroquinone
nsc 2818
ccris 2987
inchi=1/c6h6o3/c7-4-1-2-5(8)6(9)3-4/h1-3,7-9
533-73-3
1,2,4-trihydroxybenzene
benzene-1,2,4-triol
1,2,4-benzenetriol
hydroxyhydroquinone
hydroxyquinol
C02814
1,2,4-benzenetriol, reagentplus(r), 99%
H0249
BMSE000831
A829550
hqn ,
FT-0606254
AKOS015889832
CHEMBL3092389
imexine oam
1,2,4-benzenetriol [mi]
1,2,4-trihydroxybenzene [inci]
SCHEMBL33527
SY004215
mfcd00002198
1,2,4-trihydroxy benzene
monohydroxy hydroquinone
Q-200056
2-hydroxy-p-benzohydroquinone
2-hydroxy-1,4-hydroquinone
DTXSID3040930
1,2,4-benzenetriol, vetec(tm) reagent grade, 98%
DS-8585
Q903332
CS-W011167
EN300-141499
HY-W010451
Z1255438414
PD158277

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Thus, HHQ-free coffee might regulate vascular tone by improving the bioavailability of nitric oxide in SHR."( Improvement of hypertension and vascular dysfunction by hydroxyhydroquinone-free coffee in a genetic model of hypertension.
Fujii, A; Kameyama, A; Nishizawa, Y; Ohminami, H; Saito, I; Shibuya, Y; Suzuki, A; Tokimitsu, I; Yamamoto, M; Yamamoto, N, 2006
)
0.58
" Basal nitric oxide (NO) bioavailability in the aorta was determined from the contractile response induced by the NO synthase inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME, 10(-4) mol/L)."( Ferulic acid restores endothelium-dependent vasodilation in aortas of spontaneously hypertensive rats.
Fujii, A; Hase, T; Jokura, H; Saito, I; Suzuki, A; Tokimitsu, I; Yamamoto, M, 2007
)
0.34
"Ferulic acid restores endothelial function through enhancing the bioavailability of basal and stimulated NO in SHR aortas."( Ferulic acid restores endothelium-dependent vasodilation in aortas of spontaneously hypertensive rats.
Fujii, A; Hase, T; Jokura, H; Saito, I; Suzuki, A; Tokimitsu, I; Yamamoto, M, 2007
)
0.34

Dosage Studied

ExcerptRelevanceReference
" Comparison of the slopes of the dose-response curves showed that hydroquinone was 7-9 times more effective than 1,2,4,-benzenetriol and catechol at inducing DNA adducts."( Potentiation of DNA adduct formation in HL-60 cells by combinations of benzene metabolites.
Bodell, WJ; LĂ©vay, G, 1992
)
0.28
" In the present study, the dose-response for CGA in HHQ-free coffee on BP were investigated in mildly hypertensive men and women."( Hydroxyhydroquinone-free coffee: a double-blind, randomized controlled dose-response study of blood pressure.
Chikama, A; Katsuragi, Y; Mori, K; Shioya, Y; Tokimitsu, I; Watanabe, T; Yamaguchi, T, 2008
)
1.79
" As a result, a significant correlation between BP change and the three dose-response patterns was observed (p<0."( Hydroxyhydroquinone-free coffee: a double-blind, randomized controlled dose-response study of blood pressure.
Chikama, A; Katsuragi, Y; Mori, K; Shioya, Y; Tokimitsu, I; Watanabe, T; Yamaguchi, T, 2008
)
1.79
" Conversely, high catalyst dosage mainly accelerated the conversion of glucose to methyl levulinate."( Reaction pathways of glucose during esterification: effects of reaction parameters on the formation of humin type polymers.
Hu, X; Larcher, A; Li, CZ; Lievens, C, 2011
)
0.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
benzenetriolA triol in which three hydroxy groups are substituted onto a benzene ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (8)

PathwayProteinsCompounds
resorcinol degradation59
4-aminophenol degradation016
u03B3-resorcylate degradation II411
u03B3-resorcylate degradation I413
4-nitrophenol degradation II713
alkylnitronates degradation350
2,4,5-trichlorophenoxyacetate degradation622
superpathway of aromatic compound degradation3349

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Carbonic anhydrase 1Homo sapiens (human)Ki100.00000.00001.372610.0000AID1449739
Carbonic anhydrase 2Homo sapiens (human)Ki100.00000.00000.72369.9200AID1449740
Arginase-1Bos taurus (cattle)IC50 (µMol)360.00002.70002.70002.7000AID1695179
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (13)

Processvia Protein(s)Taxonomy
one-carbon metabolic processCarbonic anhydrase 1Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 2Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 2Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 2Homo sapiens (human)
angiotensin-activated signaling pathwayCarbonic anhydrase 2Homo sapiens (human)
regulation of monoatomic anion transportCarbonic anhydrase 2Homo sapiens (human)
secretionCarbonic anhydrase 2Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 2Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 2Homo sapiens (human)
positive regulation of dipeptide transmembrane transportCarbonic anhydrase 2Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 2Homo sapiens (human)
carbon dioxide transportCarbonic anhydrase 2Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 2Homo sapiens (human)
urea cycleArginase-1Bos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (6)

Processvia Protein(s)Taxonomy
arylesterase activityCarbonic anhydrase 1Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 1Homo sapiens (human)
protein bindingCarbonic anhydrase 1Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 1Homo sapiens (human)
hydro-lyase activityCarbonic anhydrase 1Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 1Homo sapiens (human)
arylesterase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 2Homo sapiens (human)
protein bindingCarbonic anhydrase 2Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 2Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
cytosolCarbonic anhydrase 1Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 1Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
myelin sheathCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 2Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (11)

Assay IDTitleYearJournalArticle
AID1474811Antibacterial activity against Escherichia coli NBRC 102203 after overnight incubation by microdilution method2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Syntheses of benzophenone-xanthone hybrid polyketides and their antibacterial activities.
AID1059430Inhibition of recombinant human IDO1 expressed in Escherichia coli EC538 using L-tryptophan as substrate at 1 mM after 1 hr relative to control2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1).
AID1449742Selectivity ratio of Ki for recombinant human carbonic anhydrase 2 to Ki for recombinant Malassezia globosa beta-carbonic anhydrase2017Bioorganic & medicinal chemistry, 05-01, Volume: 25, Issue:9
Inhibition of Malassezia globosa carbonic anhydrase with phenols.
AID1474810Antibacterial activity against Klebsiella pneumoniae NBRC 14940 after overnight incubation by microdilution method2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Syntheses of benzophenone-xanthone hybrid polyketides and their antibacterial activities.
AID1449741Selectivity ratio of Ki for recombinant human carbonic anhydrase 1 to Ki for recombinant Malassezia globosa beta-carbonic anhydrase2017Bioorganic & medicinal chemistry, 05-01, Volume: 25, Issue:9
Inhibition of Malassezia globosa carbonic anhydrase with phenols.
AID1474809Antibacterial activity against Bacillus subtilis NBRC 13719 after overnight incubation by microdilution method2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Syntheses of benzophenone-xanthone hybrid polyketides and their antibacterial activities.
AID1695179Inhibition of recombinant bovine liver ARGI using L-arginine as substrate incubated for 60 mins by spectroscopic analysis2020RSC medicinal chemistry, May-01, Volume: 11, Issue:5
Synthesis, evaluation and molecular modelling of piceatannol analogues as arginase inhibitors.
AID1449740Inhibition of human recombinant carbonic anhydrase 2 preincubated for 15 mins prior to testing measured for 10 to 100 secs by phenol red-based stopped-flow CO2 hydration assay2017Bioorganic & medicinal chemistry, 05-01, Volume: 25, Issue:9
Inhibition of Malassezia globosa carbonic anhydrase with phenols.
AID1449739Inhibition of human recombinant carbonic anhydrase 1 preincubated for 15 mins prior to testing measured for 10 to 100 secs by phenol red-based stopped-flow CO2 hydration assay2017Bioorganic & medicinal chemistry, 05-01, Volume: 25, Issue:9
Inhibition of Malassezia globosa carbonic anhydrase with phenols.
AID1474808Antibacterial activity against Staphylococcus aureus NBRC 100910 after overnight incubation by microdilution method2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Syntheses of benzophenone-xanthone hybrid polyketides and their antibacterial activities.
AID1449738Inhibition of Malassezia globosa recombinant beta-carbonic anhydrase preincubated for 15 mins prior to testing measured for 10 to 100 secs by phenol red-based stopped-flow CO2 hydration assay2017Bioorganic & medicinal chemistry, 05-01, Volume: 25, Issue:9
Inhibition of Malassezia globosa carbonic anhydrase with phenols.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (111)

TimeframeStudies, This Drug (%)All Drugs %
pre-199017 (15.32)18.7374
1990's33 (29.73)18.2507
2000's27 (24.32)29.6817
2010's29 (26.13)24.3611
2020's5 (4.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.77

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.77 (24.57)
Research Supply Index4.79 (2.92)
Research Growth Index4.71 (4.65)
Search Engine Demand Index32.40 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.77)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials5 (4.39%)5.53%
Reviews3 (2.63%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other106 (92.98%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]